Stoke Therapeutics, Inc. (STOK)

30.58 +1.16 (+3.94%) USD  |  NASDAQ  |  Jan 13, 16:00
30.65 +0.07 (+0.23%) Pre-Market: 09:14
More

Stoke Therapeutics Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for STOK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Insmed, Inc. Upgrade
Pfizer Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade